Dr Penny Sheehan

speaker

716 appearances 5 recordings 1 series first heard Jun 2026 last heard 20 Jul

Dr Penny Sheehan’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months

Recordings per month over the last 12 months — 5 in all, peaking in Jul 2026 with 3.

Appearances

newest first · ▶ plays the moment

Talking O&G - a RANZCOG Podcast · E21. Unpacking RANZCOG’s Intrapartum Fetal Surveillance Clinical Guideline (video) · 5 Jun 2026 podcast

It was just part of our overall assessment.

So the suggestion here is that services might choose to actually formalise this response and include it as a low resource, low cost, easy to perform test of fetal wellbeing.

Unfortunately, the evidence for fetal blood sampling is sadly quite scant.

But look, it can be an appropriate test where you're genuinely looking at a CTG and thinking, I'm not sure what this is trying to tell me.

When it is normal, it is a very reassuring test to exclude hypoxia.

I think the only other feature about it is that it was always kind of designed as something to put you through the next, to get through the next couple of hours if you foresaw, you know, that there would be a major change in the ability to deliver this baby in the next few hours.

So something else to consider when you're thinking about doing a fetal blood sample.

Yes, that study, unfortunately...

somewhat underfunded and we had major recruitment issues.

And I think this is one of the problems for all of these studies of CTG, intrapartum CTG particularly.

You're recruiting in the birth suite environment.

You've got to recruit beforehand, but then you've still got to gain consent right at the time that women are in.

And then judging whether a CTG falls into that some abnormalities but not a clear indication for delivery category is also quite difficult.

So, you know, you end up with quite a small pool to be able to recruit to and then so many say no.

So sadly we did not reach our target recruitment in that trial and I think that's part of the reason why we had a negative result.

And really the point of the trial was to try to generate evidence

for fetal blood sampling, but we didn't succeed.

Brave researchers who try to work in this area, to be perfectly honest.

New technologies, we've got fetal ECG analysis, we've got fetal pulse oximetry, computer decision age CTG monitoring, and then maybe in the not too distant future, AI-supported decision-making technologies

Showing 561–580 of 716 · page 29 of 36